Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.900
+0.180 (10.47%)
At close: Mar 31, 2026, 4:00 PM EDT
1.910
+0.010 (0.53%)
After-hours: Mar 31, 2026, 7:43 PM EDT
Caribou Biosciences Employees
Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year.
Employees
97
Change (1Y)
-50
Growth (1Y)
-34.01%
Revenue / Employee
$115,041
Profits / Employee
-$1,527,062
Market Cap
183.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 97 | -50 | -34.01% |
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Tonix Pharmaceuticals Holding | 142 |
| Adagene | 138 |
| Compugen | 75 |
| Acumen Pharmaceuticals | 61 |
| Elicio Therapeutics | 33 |
CRBU News
- 17 hours ago - Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy - GlobeNewsWire
- 14 days ago - Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value - Seeking Alpha
- 26 days ago - Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample - Business Wire
- 6 weeks ago - Caribou Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR® - GlobeNewsWire
- 4 months ago - Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - GlobeNewsWire
- 4 months ago - Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire